You are on the new improved site. You can view the old site in view-only mode here until June 27, 2026

Filter Results

Select search scope: search across all journals or within the current journal

Search this journal

Enter search terms…

Advanced search

/

About

About Sage
About Sage Journals
Privacy Policy
Terms of Use
Contact Us
Help

Information for

Authors
Editors
Librarians
Researchers
Reviewers
Frequently asked questions

All content on this site: Copyright © 2026 Sage Publications. All rights reserved. This website is technically supported and operated by China National Publications Import and Export (Group) Co., Ltd. 京ICP备09090397号-11

2018 Editors’ commentary

Multiple Sclerosis Journal

Impact Factor: 5.0 / 5-Year Impact Factor: 5.2

Journal Homepage Submission guidelines

Restricted access

Editorial

First published online October, 2018

2018 Editors’ commentary

, , [...], and

Volume 24, Issue 11

https://doi.org/10.1177/1352458518801764

Abstract

Get full access to this article

View all access options for this article.

References

1.

Montalban

X

Gold

R

Thompson

AJ

et al . ECTRIMS/EAN guideline on the pharmacological treatment of people with multiple sclerosis. Mult Scler 2018; 24(2): 96–120.

2.

Carroll

WM

. 2017 McDonald MS diagnostic criteria: Evidence-based revisions. Mult Scler 2018; 24(2): 92–95.

Browse journal

Current issue OnlineFirst All issues

Similar articles

Retricted access

A case–control study of risk factors for multiple sclerosis in Iran

Retricted access

Balance deficit with opened or closed eyes reveals involvement of different structures of the central nervous system in multiple sclerosis

Retricted access

Herpes encephalitis during natalizumab treatment in multiple sclerosis

Retricted access

L -amphetamine improves memory in MS patients with objective memory impairment